169 related articles for article (PubMed ID: 7959266)
21. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma.
Cohn DE; Huh WK; Fowler JM; Straughn JM
Obstet Gynecol; 2007 Jun; 109(6):1388-95. PubMed ID: 17540812
[TBL] [Abstract][Full Text] [Related]
23. The long-term survival of women with surgical stage II endometrioid type endometrial cancer.
Ayhan A; Taskiran C; Celik C; Yuce K
Gynecol Oncol; 2004 Apr; 93(1):9-13. PubMed ID: 15047207
[TBL] [Abstract][Full Text] [Related]
24. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer.
Cragun JM; Havrilesky LJ; Calingaert B; Synan I; Secord AA; Soper JT; Clarke-Pearson DL; Berchuck A
J Clin Oncol; 2005 Jun; 23(16):3668-75. PubMed ID: 15738538
[TBL] [Abstract][Full Text] [Related]
25. Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer.
Fujimoto T; Nanjyo H; Nakamura A; Yokoyama Y; Takano T; Shoji T; Nakahara K; Yamada H; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
Gynecol Oncol; 2007 Nov; 107(2):253-9. PubMed ID: 17640720
[TBL] [Abstract][Full Text] [Related]
26. Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement.
Mariani A; Webb MJ; Keeney GL; Calori G; Podratz KC
Gynecol Oncol; 2001 Oct; 83(1):72-80. PubMed ID: 11585416
[TBL] [Abstract][Full Text] [Related]
27. Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy.
Ng TY; Perrin LC; Nicklin JL; Cheuk R; Crandon AJ
Gynecol Oncol; 2000 Dec; 79(3):490-4. PubMed ID: 11104626
[TBL] [Abstract][Full Text] [Related]
28. [Endometrial adenocarcinoma treated with combined radiotherapy and surgery: 437 cases].
Touboul E; Belkacémi Y; Buffat L; Deniaud-Alexandre E; Lefranc JP; Lhuillier P; Uzan S; Jannet D; Uzan M; Antoine M; Ginesty C; Ganansia V; Jamali M; Milliez J; Blondon J; Schlienger M
Cancer Radiother; 2001 Aug; 5(4):425-44. PubMed ID: 11521391
[TBL] [Abstract][Full Text] [Related]
29. Paraaortic lymph node evaluation in stage I endometrial carcinoma.
Piver MS; Lele SB; Barlow JJ; Blumenson L
Obstet Gynecol; 1982 Jan; 59(1):97-100. PubMed ID: 7078856
[TBL] [Abstract][Full Text] [Related]
30. Pelvic lymphadenectomy in the surgical treatment of endometrial cancer.
Girardi F; Petru E; Heydarfadai M; Haas J; Winter R
Gynecol Oncol; 1993 May; 49(2):177-80. PubMed ID: 8504985
[TBL] [Abstract][Full Text] [Related]
31. The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinoma.
Neubauer NL; Havrilesky LJ; Calingaert B; Bulusu A; Bernardini MQ; Fleming ND; Bland AE; Secord AA
Gynecol Oncol; 2009 Mar; 112(3):511-6. PubMed ID: 19144394
[TBL] [Abstract][Full Text] [Related]
32. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
33. Pelvic and para-aortic lymphadenectomy for surgical staging of endometrial cancer: morbidity and mortality.
Larson DM; Johnson K; Olson KA
Obstet Gynecol; 1992 Jun; 79(6):998-1001. PubMed ID: 1579330
[TBL] [Abstract][Full Text] [Related]
34. [Stage I and II endometrial cancer: should lymphadenectomy still be done?].
Descamps P; Body G; Calais G; Moire C; Fignon A; Jourdain O; Le Floch O; Lansac J
J Gynecol Obstet Biol Reprod (Paris); 1995; 24(8):794-801. PubMed ID: 8636611
[TBL] [Abstract][Full Text] [Related]
35. Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease.
Bristow RE; Asrari F; Trimble EL; Montz FJ
Gynecol Oncol; 2001 May; 81(2):279-86. PubMed ID: 11330963
[TBL] [Abstract][Full Text] [Related]
36. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
[TBL] [Abstract][Full Text] [Related]
37. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
38. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling.
Kilgore LC; Partridge EE; Alvarez RD; Austin JM; Shingleton HM; Noojin F; Conner W
Gynecol Oncol; 1995 Jan; 56(1):29-33. PubMed ID: 7821843
[TBL] [Abstract][Full Text] [Related]
39. Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome.
Kalogiannidis I; Lambrechts S; Amant F; Neven P; Van Gorp T; Vergote I
Am J Obstet Gynecol; 2007 Mar; 196(3):248.e1-8. PubMed ID: 17346541
[TBL] [Abstract][Full Text] [Related]
40. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
